登录新浪财经APP 搜索【信披】查看更多考评等级 9月12日，周大生珠宝股份有限公司在总部会议室接待了11位来自不同机构的投资者，开展特定对象调 研活动。参与调研的机构包括易方达基金、信达澳亚、浙商资管、东方红、前海开源、红塔红土、世传 国际、国泰海通、交银国际以及华农保险。 此次调研活动中，上市公司接待人员为证券事务代表荣欢。投资者与公司围绕多个关键领域展开深入交 流。 在行业情况方面，投资者与公司进行了探讨，试图把握行业整体发展趋势。同时，2025年上半年业绩情 况成为关注焦点，投资者期望从中了解公司在该阶段的经营成果与财务表现。产品结构也是热议话题， 投资者希望明晰公司各类产品的布局与占比。 品牌矩阵方面，投资者关注公司品牌战略规划与发展方向。此外，公司与无忧传媒的合作方向也备受瞩 目，投资者试图了解双方合作将如何为公司带来新的发展机遇。分红相关事宜同样在交流范围内，投资 者关心公司的利润分配政策与计划。 调研期间，公司严格遵循《信息披露管理制度》等规定，确保信息披露真实、准确、完整、及时且公 平，未出现未公开重大信息泄露的情况。并且，现场调研的投资者均按深交所要求签署了承诺函。投资 者还参观了公司展厅 ...

Group 1 - The stock price of Lizhu Group is 41.02 yuan, down 0.65% from the previous trading day's closing price [1] - The opening price was 41.35 yuan, with a high of 41.44 yuan and a low of 40.63 yuan, and the trading volume reached 120,447 hands with a transaction amount of 493 million yuan [1] - Lizhu Group operates in the chemical pharmaceutical sector, focusing on the research, production, and sales of pharmaceutical products, including chemical preparations, traditional Chinese medicine preparations, and biological products [1] Group 2 - The latest list of the top ten circulating shareholders shows that the China Europe Medical Health Mixed Fund managed by Ge Lan has become the sixth largest circulating shareholder, holding 5.939 million shares [1] - On August 21, 30 funds participated in a research activity regarding the company, indicating strong interest from institutional investors [1] - Research reports indicate that the company's fundamentals remain stable, with balanced performance across chemical preparations, traditional Chinese medicine, and biological products [1] Group 3 - In terms of capital flow, Lizhu Group saw a net inflow of 44.4728 million yuan from main funds, accounting for 0.19% of the circulating market value [1] - Over the past five days, the cumulative net inflow of main funds was 16.4936 million yuan, representing 0.07% of the circulating market value [1]